Torrent Pharma turns towards Brazil, Germany as share of US biz halves

Share of US biz in revenues down from 40% in FY16 to 21% in FY17; Brazil, Germany grow 38% & 25%

As US business slows down owing to stiff competition and subsequent price erosion in the generic space, drug major Torrent Pharmaceuticals has turned its attention to other geographies like Brazil and Germany. In fact, Torrent's US business dipped 49.6 per cent during 2016-17, and its share in the company's overall revenues fell from 40 per cent last year to 21 per cent in FY17.

In comparison, Torrent has done well in Brazil and Germany. Its Brazil business, which was languishing in FY16 (posting a 17 per cent degrowth), grew by 38 per cent in FY17. The German business too